CEBioMeds@usm.my +604-562 2888

Mammalian Cell Culture

Synopsis

Cell culture technique is crucial to produce a significant proportion of biopharmaceuticals products as well as for diagnostic and therapeutic use. In addition, the use of mammalian cells is expanding in various applications such as drug screening, tissue engineering, gene therapy, toxicology and virology. In this module, participants will be attending lecture sessions in handling and maintaining mammalian cell lines. In addition, participants will be introduced to several lab analysis and application commonly used in cell culture work. Participants will be introduced on how to setup cell culture laboratory.

Objective

This course is designed to provide a solid basis on the management and application of cell culture for medical application. 

Learning Outcome

At the end of the course student will be able to:

1. Explain the basic aseptic technique and strategies to manage issues arise from cell culture activities. 

2. Identify the equipment and requirements needed to setup cell culture laboratory. 

3. Describe the scientific discipline related to biological safety in cell culture laboratory.

4. Understand common lab analysis related to cell culture - cell proliferation, cell migration and colour-tagging in cells via gene modification.

USM

MYR 350per module

Non USM (Local)

MYR 450per module

Non USM (International)

USD 200per module



Open Soon

DR. IDA SHAZRINA BINTI ISMAIL

PENSYARAH UNIVERSITI DS51 Ph.D (Molecular Immunology)
Expertise : Molecular targeted therapy (Small peptide inhibitor, immunomodulators in atherosclerosis, ncRNA in cancer)

Dr Ida received her MSc degree in Molecular Biology from Universiti Sains Malaysia in 2005 and a PhD in Molecular Immunology from Imperial College London, United Kingdom in 2012. Her initial work was on developing peptides capable of targeting immature dendritic cells. From there, she progressed on developing peptides against cell surface receptor on macrophages, in a quest for molecular intervention in atherosclerosis. She is also working on non-coding RNA in colorectal cancer with international collaborators at Xinxiang Medical University and Anhui Medical University in China. Her team is elucidating the roles and functions of non-coding RNA (ncRNA) in colorectal cancer and aiming at exploiting ncRNA presence and expression as potential molecular targeted therapy for cancer.

SITI RAZILA BINTI ABDUL RAZAK

PENSYARAH UNIVERSITI DS51 Ph.D (Molecular and Cellular Biology)
Expertise : Genes regulation in cancer, biomarker discovery

Siti Razila is a university lecturer at the Advanced Medical and Dental Institute, Universiti Sains Malaysia (USM). She received her first degree in Biotechnology from the Universiti Putra Malaysia. She later graduated with a Master of Science in Medical Research, from the Universiti Sains Malaysia before pursuing into Doctoral Degree programme at The University of Tokyo. She is passionate about teaching and is currently managing the program she graduated from which is the Master of Science Medical Research, a mixed mode one-year program to nurture those who are interested to become academicians and researchers as well as those who plan to pursue a doctorate in medical sciences. Her research focus is on biomarker discovery, RNA regulation in cancer, and computational biology. Her research activities involve in vitro cell culture, genetic manipulation, and in vitro functional assays to evaluate the hallmarks of cancer. Working with genetically modified cells required her to be aware of the rules and regulations of Biosafety Act 2007 that was passed by the Malaysian parliament in July 2007.

RAFEEZUL BIN MOHAMED

PENSYARAH UNIVERSITI DS51 PhD (Surrey, UK)
Expertise : Cellular Immunology, Immuno-Oncology, Immunotherapy, cardiovascular biology

Dr Rafeezul Mohamed starts his lecturer career at Advanced Medical and Dental Institute on 25 May 2013 after graduated Ph.D. from the University of Surrey UK. Previously, he obtained a degree and master in biomedical science from Universiti Sains Malaysia. His research interest is cellular immunology, immune-oncology, immunotherapy and cardiovascular biology. He has secured more than a million research grants from the Ministry of Science, Technology and Innovation, the Ministry of Higher Education, and Universiti Sains Malaysia. He also has published his research works in various reputed journals. Furthermore, he has been appointed as a national and international journal reviewer, and external and internal examiner for Ph.D. and master. Prior to this, he has graduated with several Ph.D. and master students. Finally, he also holds various administrative positions at ADMI and member of the USM human ethical research committee.

DR. SITI HAWA BINTI NGALIM

PENSYARAH UNIVERSITI DS51 PhD Pathology (UNSW, Aus) MRes Medical and Molecular Biosciences (Nanomedicine) (Newcastle U., UK) BSc Biotechnology (PennStateU, USA)
Expertise : Biointerface: Micro- and nanopatterning; Biofunctionalisation – Biomaterial; Biophysics and mechanobiology - Cell adhesion and migration; Microscopy and spectroscopy; Biomedical device and applications.

Dr Siti Hawa Ngalim is a Senior Lecturer and Primary Investigator at AMDI since 2013. Her research focuses on biointerface, which is cell interaction with the surrounding (cell-to-extracellular matrix, cell-to-cell, cell-to-engineered platforms). She is currently a member of a partner organisation of a European Union MSCA-RISE Consortium in Biotune – An international, multi-institute project that focuses on innovative approaches to bone regeneration. Apart from work at USM, she is also a contributor in contents to make science, technology, and innovation (STI) fun for all (abled and disabled communities alike); member of Future-proof Talent initiatives at the Academy of Sciences Malaysia; Ambassador for Biophysical Society (USA); an active participant in Science Policy and Science Diplomacy subject, locally and internationally.